Agilent Technologies, Inc.

Symbol: A

NYSE

145.14

USD

Market price today

  • 34.4062

    P/E Ratio

  • -1.0863

    PEG Ratio

  • 42.53B

    MRK Cap

  • 0.01%

    DIV Yield

Agilent Technologies, Inc. (A) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.51%

Operating Profit Margin

0.20%

Net Profit Margin

0.18%

Return on Assets

0.11%

Return on Equity

0.21%

Return on Capital Employed

0.14%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO:Mr. Padraig McDonnell
Full-time employees:17700
City:Santa Clara
Address:5301 Stevens Creek Boulevard
IPO:1999-11-18
CIK:0001090872

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

General Outlook

When we look at how much money they make before expenses, they keep 0.506% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.197%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.184%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.113% return, is a testament to Agilent Technologies, Inc.'s adeptness in optimizing resource deployment. Agilent Technologies, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.212%. Furthermore, the proficiency of Agilent Technologies, Inc. in capital utilization is underscored by a remarkable 0.142% return on capital employed.

Stock Prices

Agilent Technologies, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $140.56, while its low point bottomed out at $136.13. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Agilent Technologies, Inc.'s stock market.

Liquidity Ratios

Analyzing A liquidity ratios reveals its financial health of the firm. The current ratio of 268.27% gauges short-term asset coverage for liabilities. The quick ratio (188.19%) assesses immediate liquidity, while the cash ratio (108.10%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio268.27%
Quick Ratio188.19%
Cash Ratio108.10%

Profitability Ratios

A profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 19.78% underscores its earnings before tax deductions. The effective tax rate stands at 7.21%, revealing its tax efficiency. The net income per EBT, 92.79%, and the EBT per EBIT, 100.60%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 19.66%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin19.78%
Effective Tax Rate7.21%
Net Income per EBT92.79%
EBT per EBIT100.60%
EBIT per Revenue19.66%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 2.68, it details the span from stock purchase to revenue. The 2 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 520.08% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding188
Days of Inventory Outstanding113
Operating Cycle183.58
Days of Payables Outstanding54
Cash Conversion Cycle130
Receivables Turnover5.20
Payables Turnover6.81
Inventory Turnover3.22
Fixed Asset Turnover4.58
Asset Turnover0.62

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 6.69, and free cash flow per share, 5.63, depict cash generation on a per-share basis. The cash per share value, 5.97, showcases liquidity position. A payout ratio of 0.22 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.29, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share6.69
Free Cash Flow per Share5.63
Cash per Share5.97
Payout Ratio0.22
Operating Cash Flow Sales Ratio0.29
Free Cash Flow to Operating Cash Flow Ratio0.84
Cash Flow Coverage Ratio0.75
Short Term Coverage Ratio42.63
Capital Expenditure Coverage Ratio6.29
Dividend Paid and Capex Coverage Ratio3.39
Dividend Payout Ratio0.01

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 23.76%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.42, we discern the balance between debt and equity financing. The long-term debt to capitalization, 29.22%, and total debt to capitalization, 29.59%, ratios shed light on its capital structure. An interest coverage of 14.39 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio23.76%
Debt Equity Ratio0.42
Long Term Debt to Capitalization29.22%
Total Debt to Capitalization29.59%
Interest Coverage14.39
Cash Flow to Debt Ratio0.75
Company Equity Multiplier1.77

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 23.24, provides a glimpse into top-line earnings distributed across each share. Net income per share, 4.22, reflects the portion of profit attributed to each share. The book value per share, 19.88, represents the net asset value distributed per share, while the tangible book value per share, 4.80, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share23.24
Net Income Per Share4.22
Book Value Per Share19.88
Tangible Book Value Per Share4.80
Shareholders Equity Per Share19.88
Interest Debt Per Share9.78
Capex Per Share-1.01

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -0.22%, indicates top-line expansion, while the gross profit growth, -6.90%, reveals profitability trends. EBIT growth, -16.56%, and operating income growth, -16.56%, offer insights into operational profitability progression. The net income growth, -1.12%, showcases bottom-line expansion, and the EPS growth, 0.72%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-0.22%
Gross Profit Growth-6.90%
EBIT Growth-16.56%
Operating Income Growth-16.56%
Net Income Growth-1.12%
EPS Growth0.72%
EPS Diluted Growth0.24%
Weighted Average Shares Growth-1.67%
Weighted Average Shares Diluted Growth-1.33%
Dividends per Share Growth7.80%
Operating Cash Flow Growth35.06%
Free Cash Flow Growth44.37%
10-Year Revenue Growth per Share16.86%
5-Year Revenue Growth per Share51.82%
3-Year Revenue Growth per Share34.51%
10-Year Operating CF Growth per Share78.41%
5-Year Operating CF Growth per Share77.99%
3-Year Operating CF Growth per Share102.22%
10-Year Net Income Growth per Share98.65%
5-Year Net Income Growth per Share328.44%
3-Year Net Income Growth per Share81.26%
10-Year Shareholders Equity Growth per Share28.25%
5-Year Shareholders Equity Growth per Share39.74%
3-Year Shareholders Equity Growth per Share26.07%
10-Year Dividend per Share Growth per Share97.03%
5-Year Dividend per Share Growth per Share51.49%
3-Year Dividend per Share Growth per Share25.46%
Receivables Growth-8.11%
Inventory Growth-0.67%
Asset Growth2.35%
Book Value per Share Growth12.39%
Debt Growth-1.23%
R&D Expense Growth3.00%
SGA Expenses Growth-0.18%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 31,535,780,000, captures the company's total value, considering both debt and equity. Income quality, 1.43, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 41.21%, indicates the value of non-physical assets, and capex to operating cash flow, -16.82%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value31,535,780,000
Income Quality1.43
Research and Development to Revenue7.04%
Intangibles to Total Assets41.21%
Capex to Operating Cash Flow-16.82%
Capex to Revenue-4.36%
Capex to Depreciation-109.96%
Stock-Based Compensation to Revenue1.62%
Graham Number43.44
Return on Tangible Assets19.60%
Graham Net Net-6.27
Working Capital2,583,000,000
Tangible Asset Value1,410,000,000
Net Current Asset Value-732,000,000
Average Receivables1,348,000,000
Average Payables499,000,000
Average Inventory1,034,500,000
Days Sales Outstanding69
Days Payables Outstanding45
Days of Inventory On Hand112
ROIC14.49%
ROE0.21%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 6.87, and the price to book ratio, 6.87, reflect the market's valuation relative to the company's book value. The price to sales ratio, 6.32, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 25.79, and price to operating cash flows, 21.69, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio6.87
Price to Book Ratio6.87
Price to Sales Ratio6.32
Price Cash Flow Ratio21.69
Price Earnings to Growth Ratio-1.09
Enterprise Value Multiple24.96
Price Fair Value6.87
Price to Operating Cash Flow Ratio21.69
Price to Free Cash Flows Ratio25.79
Price to Tangible Book Ratio5.20
Enterprise Value to Sales4.62
Enterprise Value Over EBITDA18.50
EV to Operating Cash Flow17.80
Earnings Yield4.08%
Free Cash Flow Yield4.85%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Agilent Technologies, Inc. (A) on the NYSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 34.406 in 2024.

What is the ticker symbol of Agilent Technologies, Inc. stock?

The ticker symbol of Agilent Technologies, Inc. stock is A.

What is company IPO date?

IPO date of Agilent Technologies, Inc. is 1999-11-18.

What is company current share price?

Current share price is 145.140 USD.

What is stock market cap today?

The market cap of stock today is 42534002700.000.

What is PEG ratio in 2024?

The current -1.086 is -1.086 in 2024.

What is the number of employees in 2024?

In 2024 the company has 17700.